U.S. Food and Staples Retail Stock News

NasdaqGS:TENB
NasdaqGS:TENBSoftware

Tenable Holdings (TENB) Joins OpenAI Program, Is The Stock Fully Priced?

Tenable Holdings (TENB) is in focus after announcing it is working with OpenAI in the Daybreak Cyber Partner Program, pairing GPT-5.5 with its exposure management platform to help organizations prioritize and address cyber risks. See our latest analysis for Tenable Holdings. The OpenAI partnership arrived after a series of product updates, including expanded continuous security control and validation on the Tenable One platform. It coincides with a 90 day share price return of 52.65% and a 1...
NasdaqGS:GFS
NasdaqGS:GFSSemiconductor

Is GLOBALFOUNDRIES (GFS) Expensive Following Its SLATE Chip Advance And Infosys AI Deal?

GLOBALFOUNDRIES (GFS) stock is in focus after the company reported production readiness of its SLATE wafer-to-wafer bonding technology on the 9SW RF-SOI platform, alongside an expanded AI-led IT services partnership with Infosys. See our latest analysis for GLOBALFOUNDRIES. GLOBALFOUNDRIES' recent product and IT services announcements come after a period of strong share price momentum, with a 90 day share price return of 87.79% and a 1 year total shareholder return of 117.32%. However, the 30...
NasdaqGM:FISN
NasdaqGM:FISNConstruction

Is Deep Fission (FISN) Fairly Valued On Its 18.5 GW LOIs And Reactor Progress?

Deep Fission (FISN) is drawing attention after signing non binding Letters of Intent tied to as much as 18.5 GW of potential nuclear capacity, along with progress on its first underground reactor project in Kansas. See our latest analysis for Deep Fission. Despite the new LOIs and recent index inclusion, Deep Fission’s 1 day share price return declined 21.54% and its year to date share price return is down 32.97%, suggesting momentum has cooled quickly after the IPO. If you are interested in...
NYSE:MOG.A
NYSE:MOG.AAerospace & Defense

Will Record Quarterly Results and Earnings Beat Change Moog's (MOG.A) Narrative on Execution and Margins?

In its latest quarter, Moog reported past revenues of US$969.6 million, a 6.1% year-on-year increase that exceeded analyst expectations and delivered record financial results alongside an earnings beat. Management credited these outcomes to improved business performance and operational execution, highlighting how internal efficiency efforts are translating into stronger reported profitability. Building on these record results, we’ll explore how Moog’s earnings beat may influence its...
NYSE:BC
NYSE:BCLeisure

Is Brunswick (BC) Quietly Rebalancing From Hardware To Services With Its Freedom Boat Club Push?

In recent days, Brunswick Corporation’s Freedom Boat Club business opened its 450th global location at Liberty Landing Marina in Jersey City, New Jersey, while its Navico Group division announced operational changes at its Lowell, Michigan facility aimed at cutting fixed costs and improving efficiency. Together, the rapid expansion of Freedom Boat Club’s network and Navico Group’s cost-focused reorganization highlight Brunswick’s dual emphasis on growing accessible boating services and...
NYSE:FMC
NYSE:FMCChemicals

FMC (FMC) Sells Research Real Estate As Debt Reduction Adds To Undervalued View

FMC (FMC) has agreed to sell underused real estate at its Newark, Delaware Stine Research Center for about US$114 million, while leasing back key R&D facilities and directing the cash to debt reduction. See our latest analysis for FMC. FMC’s latest real estate and credit agreement moves come after a difficult stretch for shareholders, with the share price down 27.7% over the past 90 days and the 1 year total shareholder return falling 72%. This points to fading momentum despite recent debt...
NasdaqGM:ARDX
NasdaqGM:ARDXBiotechs

Is Ladenburg’s IBSRELA Focus Quietly Reframing Ardelyx’s (ARDX) Risk‑Reward Story?

Earlier this month, investment bank Ladenburg began covering Ardelyx, spotlighting growing demand for IBSRELA and continued commercial traction for XPHOZAH alongside management’s long-term revenue ambitions. A separate filing showed Chief Patient Officer Laura A. Williams selling about US$490,000 of stock under a pre-set plan while still retaining a large personal stake, underscoring both profit-taking and ongoing alignment with shareholders. We’ll now examine how Ladenburg’s focus on...
NYSE:BRSP
NYSE:BRSPMortgage REITs

Inflation Resilient Stocks to Watch If Higher Rates Keep Pressuring Markets

With May’s PCE inflation data expected to sit well above the Federal Reserve’s 2% target, investors are again weighing how resilient different stocks might be if higher prices and a possible July rate hike stick around. Real asset related companies with strong balance sheets and steady dividends can sometimes offer a degree of inflation defence, especially when they have room to adjust prices or use inflation linked contracts. This article looks at three stocks from our Inflation Resilient...
NasdaqGS:AVAH
NasdaqGS:AVAHHealthcare

Aveanna Healthcare Holdings (AVAH) Could Be 15% Undervalued On Rising Earnings Estimates

Aveanna Healthcare Holdings (AVAH) is back on investor radars after recent research coverage highlighted meaningful upward revisions to full year earnings estimates and an improved Zacks Rank of #2, which signals stronger analyst conviction. See our latest analysis for Aveanna Healthcare Holdings. The recent earnings upgrades and momentum signals are coming on top of a strong run, with Aveanna Healthcare Holdings posting a 90 day share price return of 28.14% and a 1 year total shareholder...
NYSE:GWRE
NYSE:GWRESoftware

Is Guidewire Software (GWRE) Undervalued After Raising Guidance On Cloud And AI Growth?

Guidewire Software (GWRE) is back in focus after its latest quarterly report highlighted strong uptake of cloud migration and AI tools among insurer clients, prompting higher guidance for revenue, operating income, and cash flow. See our latest analysis for Guidewire Software. Despite the strong quarterly update, Guidewire Software's recent share price performance has been weak. The stock is down 21.34% on a 1 month share price return and 41.20% on a year to date share price return, while the...
NYSE:LUMN
NYSE:LUMNTelecom

Lumen Technologies (LUMN) Settles Note Exchange Offers, Is The Turnaround Already Priced In?

Lumen Technologies (LUMN) is back in focus after Qwest Corporation settled previously announced exchange offers, issuing new long dated notes with fixed coupons that clarify the group’s debt profile and upcoming interest commitments. See our latest analysis for Lumen Technologies. At a share price of $8.06, Lumen Technologies has seen a 19.23% 90 day share price return and an 87.88% 1 year total shareholder return. The recent 14.35% 30 day share price decline suggests some momentum has...
NasdaqGS:MIDD
NasdaqGS:MIDDMachinery

Middleby (MIDD) After The Spin Off Approval Is The Undervalued Case Still Intact

Middleby (MIDD) is preparing to spin off its Food Processing division into a separate company, Midera Food Processing, Inc. This move will create two independent businesses with distinct priorities for restaurant equipment and food processing markets. See our latest analysis for Middleby. Middleby shares have gathered momentum around the spin off announcement, with a 30 day share price return of 14.07% and a 90 day share price return of 26.17%. The 1 year total shareholder return stands at...
NYSE:SPB
NYSE:SPBHousehold Products

Spectrum Brands (SPB) Is Up 7.0% After Oaktree Deal And Earnings Beat Has The Bull Case Changed?

Spectrum Brands Holdings recently reported stronger-than-expected fiscal 2026 results and announced a partnership with Oaktree in its Home & Personal Care segment, underscoring management’s focus on profitability and portfolio refinement. This combination of better earnings and an external partner in a core business line highlights management’s push to reshape margins and operational resilience across the group. Next, we’ll examine how the Oaktree partnership, alongside improved financial...
NasdaqGS:MSTR
NasdaqGS:MSTRSoftware

Shopify Stock And 2 High Beta US Shares Exposed To Fed Policy Shifts

Markets are on alert as Washington circles the Federal Reserve, with talk of lighter regulation, a leaner balance sheet, and less policy guidance reshaping expectations for money, credit, and risk. High beta US stocks sit right in the blast zone of these potential shifts, reacting more sharply when financial conditions change. For investors, that can mean sharper swings in both directions, but also targeted opportunities when the policy story and company fundamentals line up. This article...
NYSE:ONTO
NYSE:ONTOSemiconductor

Onto Innovation (ONTO) After Dragonfly Demand Has The Stock Looking Fully Valued

Recent analyst commentary around Onto Innovation (ONTO) has focused on strong demand for its Dragonfly G5 AI inspection platform and advanced packaging tools, drawing attention to where the stock currently trades. See our latest analysis for Onto Innovation. Recent price momentum has been strong, with Onto Innovation’s share price return of 22.88% over the past 30 days and 57.38% over 90 days, alongside a 1 year total shareholder return of 232.07%. This points to rising enthusiasm around its...
NYSE:BZH
NYSE:BZHConsumer Durables

Beazer Homes Stock In Focus As Housing Policy Uncertainty Hits Homebuilders

The sudden halt to a bipartisan housing bill and rising political tension around the SAVE America Act have thrown fresh uncertainty over the housing market, from homebuilders to institutional owners of single family rentals. For investors, that kind of policy limbo can reshape risk and opportunity faster than earnings reports do. This article looks at how that news flows through to the Homebuilders & Residential Construction screener and what that could mean for your portfolio decisions...
NasdaqCM:SIFY
NasdaqCM:SIFYTelecom

Is Sify Technologies (SIFY) Undervalued After Its $71 Million Data Center Loan?

Sify Technologies (NasdaqCM:SIFY) is in focus after securing a $71 million sustainability linked loan from the International Finance Corporation to help fund two new data centers in Navi Mumbai and Chennai. See our latest analysis for Sify Technologies. At a share price of $14.84, Sify Technologies has pulled back in the short term, with the 1 day, 7 day and 30 day share price returns all in decline. However, the 90 day share price return of 11.5%, year to date share price return of 20.8% and...
NasdaqGS:FRMI
NasdaqGS:FRMISpecialized REITs

Nvidia And Western Digital Lead 3 AI Infrastructure Stocks Retail Investors Are Watching

The AI Infrastructure Stocks screener focuses on the hardware backbone that makes AI possible, at a time when global data, energy and inflation trends are front of mind for markets. With manufacturing PMIs firming in the US, services growth mixed in Europe and the UK, and central banks still wrestling with inflation, many investors are looking for business models tied to real assets and cash flow. This screener concentrates on companies that help build and run the specialized data centers,...
NasdaqGS:IDYA
NasdaqGS:IDYABiotechs

IDEAYA Biosciences (IDYA) First Patient Enrollment Puts Valuation Back In Focus

Why IDEAYA Biosciences Stock Is Back in Focus IDEAYA Biosciences (IDYA) is drawing renewed investor attention after enrolling the first patient in a Phase 1 trial that pairs IDE892 with IDE397 in MTAP-deleted solid tumors. The study centers on cancers such as non-small cell lung and pancreatic, where MTAP deletions are relatively common and no approved targeted therapies currently exist. This development is making IDEAYA Biosciences stock a focal point for investors watching early clinical...
NasdaqGS:BL
NasdaqGS:BLSoftware

3 Software Stocks Built For Rising Compliance Demand

Regulation is back in focus, and for many investors that can feel like a moving target. With new rules, shifting fiscal policy, changing interest rate expectations, and fresh economic data, some technology stocks appear better positioned than others to handle tighter oversight and evolving compliance demands. This Regulation-Resilient Technology Companies screener filters for large tech firms that already talk explicitly about regulation or compliance and that currently score well on measures...
NYSE:ATO
NYSE:ATOGas Utilities

Atmos Energy (ATO) Could Be 7% Undervalued As Its Growth Narrative Holds

Atmos Energy stock reacts to recent performance data Atmos Energy (ATO) has drawn investor attention after recent performance figures highlighted a mix of share price moves and fundamental data, prompting closer scrutiny of how its gas distribution and pipeline operations align with current expectations. See our latest analysis for Atmos Energy. The recent 1 day share price return of 0.88% has not offset the 30 day share price decline of 2.94% and 90 day decline of 5.78%. However, longer term...
NYSE:FIGS
NYSE:FIGSLuxury

FIGS (FIGS) Could Be 16% Undervalued As Growth Questions Linger

FIGS (FIGS) has recently drawn investor attention after its shares moved sharply, with the stock up 6.8% in the latest session but down over the past week and month. That short term volatility is prompting closer scrutiny. See our latest analysis for FIGS. Looking past the latest move, FIGS has a 1-year total shareholder return of 108.13% alongside a 90-day share price return that declined 23.66%. This suggests recent momentum has cooled after a strong longer term run as investors reassess...
NasdaqGS:ALKT
NasdaqGS:ALKTSoftware

Can Alkami Technology’s (ALKT) Landmark Success Clarify Its Edge In Small-Business Banking Software?

In recent days, Alkami Technology, Inc. highlighted the past success of its partnership with Landmark Credit Union, showing how Landmark accelerated its digital transformation and upgraded both retail and business member experiences using Alkami’s cloud-based platform. An important takeaway is that Landmark Credit Union scaled its commercial banking program using Alkami’s business and commercial capabilities, indicating how the platform can support deeper penetration into small-business and...
NasdaqGS:GH
NasdaqGS:GHHealthcare

Guardant Health (GH) Could Be 16% Below Fair Value On FDA Approval Win

Guardant Health (GH) is back in focus after the U.S. Food and Drug Administration approved its Guardant360 CDx liquid biopsy as a companion diagnostic for Boehringer Ingelheim’s newly approved HERNEXEOS lung cancer therapy. See our latest analysis for Guardant Health. The recent FDA approval arrives as momentum in Guardant Health's stock has been strong, with a 90-day share price return of 55.58% and a 1-year total shareholder return of 174.69%. This indicates that investors are reassessing...